Results 151 to 160 of about 9,927 (189)
Some of the next articles are maybe not open access.

Related searches:

Gastric emptying of enteric-coated tablets

Digestive Diseases and Sciences, 1984
To evaluate the gastric emptying time of pharmaceutical dosage forms in a clinical setting, a relatively simple dual-radionuclide technique was developed. Placebo tablets of six different combinations of shape and size were labeled with indium-111 DTPA and enteric coated. Six volunteers participated in a single-blind and crossover study.
B. D. Rosenek   +5 more
openaire   +3 more sources

Population pharmacokinetics and IVIVC for mesalazine enteric-coated tablets

Journal of Controlled Release, 2022
Although in-vivo bioequivalence (BE) study serves as a golden standard for establishing interchangeability of oral dosage forms, it remains challenging for products with high inter-subject variability such as mesalazine enteric-coated tablet to fulfil the BE criteria set by regulatory authorities.
Yufeng, Zhang   +5 more
openaire   +2 more sources

GLC Determination of Erythromycin in Enteric-coated Tablets

Journal of Pharmaceutical Sciences, 1972
A GLC assay method for erythromycin in tablets is described. This method involves the extraction, silylation, and chromatography of erythromycin from tablets, and it yields an average recovery of 100.6% with a coefficient of variation of about 2%.
John H. Robertson, Kiyoshi Tsuji
openaire   +3 more sources

Development and Evaluation of Enteric-Coated Penicillamine Tablets

Journal of Pharmaceutical Sciences, 1984
Commercially available 250-mg penicillamine tablets were converted into enteric-coated tablets. Based on in vitro dissolution and disintegration tests, tablets coated with five layers of a cellulose acetate phthalate formulation by a modified pan coating technique were judged to be superior to other coated tablets. These tablets resisted disintegration
Diana A. Chambliss   +5 more
openaire   +3 more sources

Kinetics of release from enteric-coated tablets.

Pharmaceutical research, 1988
Controlled and localized release of drugs in the intestine can be achieved by enteric coating. The design of enteric-coated tablets has so far remained empirical, in part because of the lack of a quantitative description of the drug release kinetics. In this paper, a mathematical model is presented that describes the dissolution of the polymer coating ...
Palsson, Bernhard Ø   +3 more
openaire   +4 more sources

Comparison of the Gastrointestinal Side Effects of Naproxen Formulated as Plain Tablets, Enteric-Coated Tablets, Or Enteric-Coated Granules in Capsules

Scandinavian Journal of Gastroenterology, 1989
We studied the gastrointestinal side effects of three formulations of naproxen in 18 healthy male volunteers. In a Latin-square design crossover study, the subjects received 500 mg naproxen twice daily for 7 days as plain tablets, enteric-coated tablets, or enteric-coated granules in capsules.
S. Larsen   +5 more
openaire   +3 more sources

Home - About - Disclaimer - Privacy